Business Context and Reporting Period
Company: Neuronetics, Inc. (STIM)
Filing Type: Form 8-K (Current Report)
Date of Report: August 11, 2024
Event: Entry into a Material Definitive Agreement to acquire Greenbrook TMS Inc. via a Plan of Arrangement under Ontario law.
Key Financial Metrics and Transaction Terms
This filing details a proposed merger rather than periodic financial results. Key transaction metrics include:
- Consideration: Neuronetics will issue an aggregate of 25,304,971 shares of its common stock to Greenbrook shareholders.
- Ownership Structure: Post-transaction, Greenbrook shareholders are expected to hold 43% of the combined company, while Neuronetics stockholders will hold 57% (on a fully diluted basis).
- Termination Fees: A fee of $1,900,000 is payable by either party under specified circumstances (e.g., failure to obtain shareholder approval, breach of non-solicitation, or pursuit of a superior proposal).
- Transaction Expense Cap: Greenbrook transaction expenses must not exceed $4,250,000.
- Tax Cap: Aggregate cash taxes arising from debt conversion and settlement must not exceed $1,000,000.
Note: The filing does not provide specific revenue, profit, cash flow, or debt figures for either company.
Material Changes and Governance
The primary material change is the proposed combination of Neuronetics and Greenbrook. Key governance and structural changes include:
- Board Composition: The post-transaction Neuronetics board will consist of seven directors: five appointed by Neuronetics and two appointed by Madryn Asset Management LP (a key Greenbrook shareholder).
- Debt Conversion: A condition to closing is the conversion of all outstanding debt under Greenbrook's credit facility with Madryn and its subordinated convertible notes into Greenbrook shares.
- Equity Treatment: Greenbrook options and warrants will be converted into shares based on market price calculations; performance share units and restricted share units will be cancelled for no consideration.
Guidance, Outlook, Risks, and Conditions
Conditions to Closing: The transaction is subject to customary conditions, including:
- Approval by stockholders of both Neuronetics and Greenbrook.
- Interim and final orders from the Ontario Superior Court of Justice.
- Exemption from registration requirements under Section 3(a)(10) of the Securities Act.
- Consent from Neuronetics' lender (Perceptive Credit Holdings LV, LP).
- No material adverse effect occurring to either party.
- Greenbrook accounts payable days not exceeding 71 days.
Outlook and Timeline: The transaction must be completed on or before December 10, 2024 (the "Outside Date"), unless extended by mutual agreement.
Risks and Contingencies: The filing highlights significant risks, including the potential failure to meet the Outside Date, inability to obtain shareholder or regulatory approvals, disruption of business operations, and the possibility of either party paying a termination fee if a superior proposal is pursued or the deal fails.
Investor Verification Checklist
- Verify the final approval status of the Arrangement by both Neuronetics and Greenbrook shareholders.
- Confirm the receipt of the final order from the Ontario Superior Court of Justice.
- Monitor the status of the debt conversion for Greenbrook's credit facility and subordinated notes.
- Review the upcoming joint proxy statement for detailed financial projections and risk factors.
- Check for any announcements regarding superior proposals or changes in board recommendations prior to the Outside Date.